Levomepromazine
Indication
Schizophrenia (Existing Patients)
The colour classification was determined as part of the collaborative work between LCFT and Medicines Management leads. Local pathways and patient safety were taken into consideration.
Amber level 0
Brand:
Nice TA:
Commissioning responsibility:
PbR excluded:
No
BNF chapter:
Central nervous system
Background
LSCMMG has adopted this local position as part of collaboration between provider trusts and CCG Medicines Management leads
Recommendation
LSCMMG Recommendation:
Amber level 0
Reason for decision:
Suitable for GP prescribing following recommendation/initiation by specialist
Supporting documents: